Publications

Found 3 results
Filters: Author is L. Ni  [Clear All Filters]
2010
L. Yang, Wang, L. J., Shi, G. L., Ni, L., Song, C. X., Zhang, Z. X., and Xu, S. F., Analysis of HLA-A, HLA-B and HLA-DRB1 alleles in Chinese patients with lung cancer, vol. 9, pp. 750-755, 2010.
Ainsworth PJ, Surh LC and Coulter-Mackie MB (1991). Diagnostic single strand conformational polymorphism (SSCP): a simplified non-radioisotopic method as applied to a Tay-Sachs B1 variant. Nucleic Acids Res. 19: 405-406. http://dx.doi.org/10.1093/nar/19.2.405 PMid:2014179 PMCid:333615   Bidwell JL, Bidwell EA, Savage DA, Middleton D, et al. (1988). A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10. Transplantation 45: 640-646. http://dx.doi.org/10.1097/00007890-198803000-00027 PMid:2894727   Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, et al. (1987). The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329: 512-518. http://dx.doi.org/10.1038/329512a0 PMid:2443855   Cantú de León D, Perez-Montiel D, Villavicencio V, Garcia CA, et al. (2009). High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study. BMC Cancer 9: 48. http://dx.doi.org/10.1186/1471-2407-9-48 PMid:19196481 PMCid:2653544   Chen WQ, Zhang SW and Kong LS (2008). Cancer mortality report of 34 registries in China, 2004. Bull. Chin. Cancer 17: 913-916.   Dalva K and Beksac M (2007). HLA typing with sequence-specific oligonucleotide primed PCR (PCR-SSO) and use of the Luminex technology. Methods Mol. Med. 134: 61-69. http://dx.doi.org/10.1007/978-1-59745-223-6_5 PMid:17666743   Davis RW, Thomas M, Cameron J, St John TP, et al. (1980). Rapid DNA isolations for enzymatic and hybridization analysis. Methods Enzymol. 65: 404-411. http://dx.doi.org/10.1016/S0076-6879(80)65051-4   Dorak MT, Oguz FS, Yalman N, Diler AS, et al. (2002). A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL. Leuk. Res. 26: 651-656. http://dx.doi.org/10.1016/S0145-2126(01)00189-8   Ferlay J, Autier P, Boniol M, Heanue M, et al. (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 18: 581-592. http://dx.doi.org/10.1093/annonc/mdl498 PMid:17287242   Gresner P, Gromadzinska J and Wasowicz W (2007). Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer 57: 1-25. http://dx.doi.org/10.1016/j.lungcan.2007.02.002 PMid:17337085   Haghpanah V, Khalooghi K, Adabi K, Amiri P, et al. (2009). Associations between HLA-C alleles and papillary thyroid carcinoma. Cancer Biomark. 5: 19-22. PMid:19242058   Hoppe B and Salama A (2007). Sequencing-based typing of HLA. Methods Mol. Med. 134: 71-80. http://dx.doi.org/10.1007/978-1-59745-223-6_6 PMid:17666744   Jemal A, Siegel R, Ward E, Hao Y, et al. (2009). Cancer statistics, 2009. CA Cancer J. Clin. 59: 225-249. http://dx.doi.org/10.3322/caac.20006 PMid:19474385   Kiyohara C, Takayama K and Nakanishi Y (2006). Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 54: 267-283. http://dx.doi.org/10.1016/j.lungcan.2006.08.009 PMid:16982113   Kübler K, Arndt PF, Wardelmann E, Krebs D, et al. (2006). HLA-class II haplotype associations with ovarian cancer. Int. J. Cancer 119: 2980-2985. http://dx.doi.org/10.1002/ijc.22266 PMid:17016821   Madeleine MM, Johnson LG, Smith AG, Hansen JA, et al. (2008). Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res. 68: 3532-3539. http://dx.doi.org/10.1158/0008-5472.CAN-07-6471 PMid:18451182 PMCid:2662593   Marsh SG (2003). HLA nomenclature and the IMGT/HLA sequence database. Novartis Found. Symp. 254: 165-173. http://dx.doi.org/10.1002/0470090766.ch11 PMid:14712937   Miller SA, Dykes DD and Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215. http://dx.doi.org/10.1093/nar/16.3.1215 PMid:3344216 PMCid:334765   Mundhada S, Luthra R and Cano P (2004). Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11). BMC Cancer 4: 25. http://dx.doi.org/10.1186/1471-2407-4-25 PMid:15202948 PMCid:441382   Olerup O and Zetterquist H (1992). HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39: 225-235. http://dx.doi.org/10.1111/j.1399-0039.1992.tb01940.x PMid:1357775   Parkin DM, Bray F, Ferlay J and Pisani P (2005). Global cancer statistics, 2002. CA Cancer J. Clin. 55: 74-108. http://dx.doi.org/10.3322/canjclin.55.2.74 PMid:15761078   Quintero E, Pizarro MA, Rodrigo L, Pique JM, et al. (2005). Association of Helicobacter pylori-related distal gastric cancer with the HLA class II gene DQB10602 and cagA strains in a southern European population. Helicobacter 10: 12-21. http://dx.doi.org/10.1111/j.1523-5378.2005.00287.x PMid:15691311   Schiff MA, Apple RJ, Lin P, Nelson JL, et al. (2005). HLA alleles and risk of cervical intraepithelial neoplasia among southwestern American Indian women. Hum. Immunol. 66: 1050-1056. http://dx.doi.org/10.1016/j.humimm.2005.09.002 PMid:16386646   Terasaki PI and McClelland JD (1964). Microdroplet assay of human serum cytotoxins. Nature 204: 998-1000. http://dx.doi.org/10.1038/204998b0 PMid:14248725   Tokumoto H (1998). Analysis of HLA-DRB1-related alleles in Japanese patients with lung cancer - relationship to genetic susceptibility and resistance to lung cancer. J. Cancer Res. Clin. Oncol. 124: 511-516. http://dx.doi.org/10.1007/s004320050207 PMid:9808426   Wu MS, Hsieh RP, Huang SP, Chang YT, et al. (2002). Association of HLA-DQB1*0301 and HLA-DQB1*0602 with different subtypes of gastric cancer in Taiwan. Jpn. J. Cancer Res. 93: 404-410. http://dx.doi.org/10.1111/j.1349-7006.2002.tb01271.x PMid:11985790   Wu Y, Liu B, Lin W, Xu Y, et al. (2007). Human leukocyte antigen class II alleles and risk of cervical cancer in China. Hum. Immunol. 68: 192-200. http://dx.doi.org/10.1016/j.humimm.2006.07.005 PMid:17349874   Yari F, Sobhani M, Sabaghi F, Zaman-Vaziri M, et al. (2008). Frequencies of HLA-DRB1 in Iranian normal population and in patients with acute lymphoblastic leukemia. Arch. Med. Res. 39: 205-208. http://dx.doi.org/10.1016/j.arcmed.2007.09.009 PMid:18164964   Yoshimura C, Nomura S, Yamaoka M, Ohtani T, et al. (2000). Analysis of serum ErbB-2 protein and HLA-DRB1 in Japanese patients with lung cancer. Cancer Lett. 152: 87-95. http://dx.doi.org/10.1016/S0304-3835(99)00437-1   Young NT and Darke C (1993). Allelic typing of the HLA-DR4 group by polymerase chain reaction-single-strand conformation polymorphism analysis. Hum. Immunol. 37: 69-74. http://dx.doi.org/10.1016/0198-8859(93)90144-P   Zhang SW, Chen WQ and Lei ZI (2008). A report of cancer incidence from 37 cancer registries in China, 2004. Bull. Chin. Cancer 17: 909-912.